Company: AEMD
Filing Date: 2025-08-21
Form Type: 8-K
Source: 0001683168-25-006360
Chunk: 0

Company: AETHLON MEDICAL INC
Filing Date: 2025-08-21
Form: 8-K
Item: Item 7.01
Chunk 0
---
Item 7.01 Regulation FD Disclosures.

On August 20, 2025, Aethlon
Medical, Inc. (the “ Company”) made available an updated corporate presentation (the “ Presentation”) that may be
used by the Company in connection with presentations at conferences and investor meetings. The Presentation can be found on the
Company’s website, www. aethlonmedical. com. The Presentation is furnished as Exhibit 99.1 hereto.

The information in the
Presentation is being furnished, not filed, pursuant to this Item 7.01. Accordingly, the information in the Presentation will not be deemed
filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “ Exchange Act”), or otherwise
subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any other filing under the Securities
Act of 1933, as amended (the “ Securities Act”), or the Exchange Act, except as expressly set forth by specific reference in
such a filing. The furnishing of the information in this Current Report on Form 8-K with respect to the Presentation is not
intended to, and does not, constitute a determination or admission by the Company that the information in this Current Report on Form
8-K with respect to the Presentation is material or complete, or that investors should consider this information before making an investment
decision with respect to any security of the Company.

Item 9.01 Financial
Statements and Exhibits.

(d) Exhibits

  Exhibit Number      Description                                                                  
 ───────────────────────────────────────────────────────────────────────────────────────────────────
            99.1      Presentation Materials                                                       
             104      Cover Page Interactive Data File (embedded within the inline XBRL Document)  

   2  

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

  Date: August 21, 2025      Aethlon Medical, Inc.                                                           
 ─────────────────────────────────────────────────────────────────────────────────────────────────────────────
                             By:                        /s/ James B. Frakes                                  
                             Name:                      James B. Frakes                                      

   3